Neos Therapeutics, Inc. 8-K
Accession 0001213900-21-016770
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 6:11 AM ET
Size
817.2 KB
Accession
0001213900-21-016770
Documents
- 8-Kea138106-8k_neostherapeutics.htmPrimary
CURRENT REPORT
- EX-3.1ea138106ex3-1_neostherap.htm
FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF NEOS THERAPEUTICS, INC
- EX-3.2ea138106ex3-2_neostherap.htm
SECOND AMENDED AND RESTATED BYLAWS OF NEOS THERAPEUTICS, INC
- EX-10.1ea138106ex10-1_neostherap.htm
CONSENT, WAIVER AND SIXTH AMENDMENT TO FACILITY AGREEMENT, BY AND AMONG AYTU BIOSCIENCE, INC., NEOS THERAPEUTICS, INC., NEOS THERAPEUTICS BRANDS, LLC, NEOS THERAPEUTICS, LP, NEOS THERAPEUTICS COMMERCIAL, LLC, PHARMAFAB TEXAS, LLC, DEERFIELD PRIVATE DESIGN
- EX-10.2ea138106ex10-2_neostherap.htm
CONSENT, WAIVER AND AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT, BY AND AMONG AYTU BIOSCIENCE, INC., NEOS THERAPEUTICS, INC., NEOS THERAPEUTICS BRANDS, LLC, NEOS THERAPEUTICS, LP, NEOS THERAPEUTICS COMMERCIAL, LLC, PHARMAFAB TEXAS, AND ENCINA BUSINESS
- EX-99.1ea138106ex99-1_neostherap.htm
PRESS RELEASE DATED MARCH 22, 2021
Issuer
Neos Therapeutics, Inc.
CIK 0001467652
Related Parties
1- filerCIK 0001467652
Filing Metadata
- Form type
- 8-K
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 6:11 AM ET
- Size
- 817.2 KB